Hadland, Scott E and Park, Tae Woo and Bagley, Sarah M (2018) Stigma associated with medication treatment for young adults with opioid use disorder: a case series. Addiction Science & Clinical Practice, 13, (15), https://doi.org/10.1186/s13722-018-0116-2.
External website: https://ascpjournal.biomedcentral.com/articles/10....
Background: Opioid-related overdose deaths in the US have risen sharply among young adults. Despite this increase, access to evidence-based medication for opioid agonist treatment (OAT) for youth remains low. Among older adults, barriers to OAT include the paucity of buprenorphine-waivered prescribers and low rates of prescribing among waivered physicians. We have increasingly found in our clinical practice significant stigma related to using OAT to treat addiction for young adults. In this series, we describe three cases of young adults who faced significant stigma related to their treatment.
E Concepts in biomedical areas > Medical substance > Prescription drug (medicine / medication)
F Concepts in psychology > Psychological stress / emotional trauma
HJ Treatment method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
J Health care, prevention, harm reduction and rehabilitation > Treatment and maintenance > Patient / client attitude toward treatment
J Health care, prevention, harm reduction and rehabilitation > Treatment and maintenance > Provider / worker / staff attitude toward treatment
MA-ML Social science, culture and community > Sociocultural discrimination > Prejudice (stigma / discrimination)
T Demographic characteristics > Young adult
VA Geographic area > United States
Repository Staff Only: item control page